EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteogenomic Characterization Reveals Metabolic Vulnerabilities and Aberrant Phosphorylation in Colorectal Metastasis to Liver

Wensi Zhao, Lei Zhao, Yannan Lian, Zhiwei Liu, Yaqi Li, Xuege Wang, Mingya Zhang, Ni Li, Jingli Guo, Danqing Shen, Shaobo Mo, Jiahao Li und 9 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202511744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Wensi Zhao und 20 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital, and Cancer Center, School of Medicine, Tong…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Proteogenomics. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Strategic Priority Research Program of the Chinese Academy of Sciences, Guangdong High-level New R&D Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal liver metastasis (CRLM) is one of the leading death causes among colorectal cancer (CRC) patients, yet its underlying molecular events remain poorly understood, particularly at the proteomic and phosphoproteomic levels. A proteogenomic analysis combining genomics, transcriptomics, proteomics, and phosphoproteomics is performed on 102 samples from 34 treatment‐naïve CRLM patients, including primary CRC, adjacent normal colorectal, and matched liver metastasis tissues. CRC cell lines, organoids, mouse models, and an independent patient cohort are used to validate the findings. Proteomics and phosphoproteomics show profoundly dysregulated pathways in liver metastasis tissues, notably disruptions in carbon metabolism. Functional validation using CRC organoids and mouse models demonstrates that the one‐carbon metabolism enzyme SHMT1 promotes CRC tumorigenesis and metastasis via formate‐mediated AMPK inhibition, whereas PIM kinase‐dependent NDRG1 Ser330 phosphorylation exacerbates liver metastasis by promoting ubiquitin‐dependent degradation of NDRG1. Unsupervised clustering identifies two proteomic subtypes of liver metastasis samples with distinct clinical outcomes: a poor‐prognosis C1 (metabolism) subtype and a better‐prognosis C2 (RNA function) subtype. Considering expression frequency, specificity, and functional relevance, FTCD, GPD1, SOD2, and EIF4B Ser422 phosphorylation are further identified and validated as subtype prognostic biomarkers. This study provides critical insights into the molecular mechanisms underlying CRLM and offers resources for high‐risk metastatic CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLiver NeoplasmsProteogenomicsHumansAnimalsMicePhosphorylationFemaleMaleProteomicsCell Line, Tumor

Stichwörter der Autor:innen

SHMT1biomarkercolorectal liver metastasisphosphoproteomicsproteomic subtypeproteomics

Autor:innen und Institutionen

  • Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital, and Cancer Center, School of Medicine, Tongji University, Shanghai, 200434, China.
  • Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China.
  • Shanghai Key Laboratory of Intelligent Information Processing, School of Computer Science and Technology, Fudan University, Shanghai, 200433, China.

ORCID-Profile: Minjia Tan

Förderung

  • National Natural Science Foundation of China
  • Strategic Priority Research Program of the Chinese Academy of Sciences
  • Guangdong High-level New R&D Institute
  • Guangdong High-level Innovative Research Institute
  • Zhongshan Science and Technology Bureau
  • Innovative Research Team of High-Level Local Universities in Shanghai
  • Jinfeng startup funding in Chongqing

Zitieren

APA

Zhao, W., Zhao, L., Lian, Y., Liu, Z., Li, Y., Wang, X., Zhang, M., Li, N., Guo, J., Shen, D., Mo, S., Li, J., Zhai, L., Ni, J., Lee, S., Liu, B., Li, J., Wang, F., Peng, J., …, & Tan, M. (2026). Proteogenomic Characterization Reveals Metabolic Vulnerabilities and Aberrant Phosphorylation in Colorectal Metastasis to Liver. Advanced Science. https://doi.org/10.1002/advs.202511744

Vancouver

Zhao W, Zhao L, Lian Y, Liu Z, Li Y, Wang X, et al. Proteogenomic Characterization Reveals Metabolic Vulnerabilities and Aberrant Phosphorylation in Colorectal Metastasis to Liver. Advanced Science. 2026. doi:10.1002/advs.202511744

BibTeX
@article{Zhao2026,
  author = {Zhao, Wensi and Zhao, Lei and Lian, Yannan and Liu, Zhiwei and Li, Yaqi and Wang, Xuege and Zhang, Mingya and Li, Ni and Guo, Jingli and Shen, Danqing and Mo, Shaobo and Li, Jiahao and Zhai, Linhui and Ni, Jiahui and Lee, Sangkyu and Liu, Bin and Li, Jing and Wang, Fei and Peng, Junjie and Qin, Jun and Tan, Minjia},
  title = {Proteogenomic Characterization Reveals Metabolic Vulnerabilities and Aberrant Phosphorylation in Colorectal Metastasis to Liver},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202511744}
}
Kostenlos starten →